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Abstract 
It is over 100 years since the life-cycle of the malaria parasite Plasmodium was discovered, yet 
its intricacies remain incompletely understood - a knowledge gap that may prove crucial for our 
efforts to control the disease. Phenotypic screens have partially filled the void in the antimalarial 
drug market, but as compound libraries eventually become exhausted, new medicines will only 
come from directed drug development based on a better understanding of fundamental parasite 
biology. This review focusses on the unusual cell cycles of Plasmodium, which may present a 
rich source of novel drug targets as well as a topic of fundamental biological interest. 
Plasmodium does not grow by conventional binary fission, but rather by several syncytial modes 
of replication including schizogony and sporogony. Here, we collate what is known about the 
various cell cycle events and their regulators throughout the Plasmodium life-cycle, highlighting 
the differences between Plasmodium, model organisms and other apicomplexan parasites and 
identifying areas where further study is required. The possibility of DNA replication and the cell 
cycle as a drug target is also explored. Finally the use of existing tools, emerging technologies, 
their limitations and future directions to elucidate the peculiarities of the Plasmodium cell cycle 
are discussed. 
Keywords: Malaria, Plasmodium, Cell cycle, Replication 
 
Background 
Manuscript Click here to download Manuscript PARV-D-18-00008_R2
EDIT SG CJM.docx
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
The malaria parasite owes its success in part to its ability to ‘divide and conquer’ [1]. It pursues a 
complex, two-host life-cycle involving both mosquito and human hosts, in which each 
bottleneck is followed by a replication phase (Fig. 1). There are four periods of mitotic DNA 
synthesis and one period of meiosis during the course of the Plasmodium life-cycle [2]. The 
properties of cell division at these replication phases differ fundamentally from conventional 
models of eukaryotic cell division: rather than binary fission, the parasite opts primarily for 
schizogony whereby a multinucleate syncytium is formed, prior to budding and cytokinesis [3]. 
Equally intriguing is the remarkably rapid process of gamete formation, where male gametocytes 
undergo three rounds of DNA replication in a matter of minutes, producing eight male gametes 
[4, 5]. 
Such a complex life-cycle presumably requires sophisticated global and local regulators, 
involving refined checkpoint and DNA repair mechanisms [3], yet these are currently only 
poorly understood. Along with the unusual spatial and temporal dynamics of DNA replication, 
cell cycle regulators have been shown to be distinct from human counterparts [6]. Thus, 
replication in Plasmodium appears to be an excellent drug target: its mechanisms and regulators 
are distinct from those of the host organisms, the scale of reproductive output is directly crucial 
to pathogenicity, and it offers the possibility of interfering with the transmissibility of the 
parasite. Furthermore, the parasite possesses two organelles of bacterial origin, the apicoplast 
and mitochondrion, both of which carry their own genomes and may harbour distinct drug 
targets in the form of prokaryotic-type replication proteins (apicoplast replication was recently 
well-reviewed [7], so this article focusses only on nuclear replication). Finally, in the current era 
of artemisinin resistance, which appears to involve parasite ‘dormancy’, understanding cell cycle 
arrest and checkpoints is of utmost importance. 
 
The Plasmodium cell cycle 
The standard eukaryotic cell cycle follows a clearly defined series of stages during which the cell 
grows (interphase), replicates its chromosomes (S phase) and divides (M phase), with S phase 
often being flanked by two gap phases called G1 and G2 (Fig. 2). The process is tightly regulated 
by an extensive regulatory network that ensures the cell is ready to progress onwards through the 
cycle after each phase [8, 9]. Apicomplexans, including Plasmodium spp., deviate significantly 
from this classical model, allowing each cell to produce dozens or hundreds of new daughter 
cells during a single replicative cycle. At the heart of these adaptations is schizogony: a syncytial 
and yet asynchronous form of replication and cell division, which occurs in the mammalian host 
during hepatic and erythrocytic infections, while a largely analogous process called sporogony 
occurs in the mosquito vector during oocyst formation (Fig. 1). 
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For the most virulent human malaria parasite, P. falciparum, the parasites in the 
erythrocytic cycle, when grown in vitro, produce an average of 16 daughter merozoites from a 
single infected erythrocyte. Of these, about two-thirds can successfully invade new erythrocytes, 
resulting in growth rates of up to 11-fold per 48-hour cycle [10, 11]. Infected hepatocytes and 
oocysts have been less closely studied, but each of these can produce many thousands of 
daughter cells during a single replicative cycle, taking ~ 7–10 days. Finally, the extremely rapid 
replicative process of male gametogenesis takes just 10–15 minutes (Table 1). Thus, there are 
huge variations of both speed and magnitude between the various replicative stages of the 
Plasmodium life-cycle. 
 
Cell-cycle mechanics at the cellular level 
The Plasmodium cell cycle is best characterised during erythrocytic schizogony, with the start of 
each cycle being associated with the invasion of a new erythrocyte by a merozoite. During the 
first 24 hours post-invasion (hpi), ring and early-trophozoite parasites possesses a single haploid 
nucleus in interphase or G1. The centriolar plaque (CP), which is functionally equivalent to the 
centrosomes in higher eukaryotes, begins to assemble and duplicate 20–24 hpi, marking the shift 
from growth to replication. Replication of the chromosomes initiates at estimated times of 29 hpi 
[12] or 24–26 hpi [13], overlapping with the semi-conservative duplication of the CP. It was 
initially proposed that several rounds of continual chromosome replication would then occur, 
followed by a single co-ordinated mass chromosome segregation, nuclear division and formation 
of daughter merozoites [14]; however, an alternative model entails repeated cycles of replication, 
segregation and nuclear envelope division, based upon the observed segregation patterns of the 
CP [13]. In this model the characteristic asynchronicity of schizogony correlates with the 
inheritance of the CP, with nuclei that inherit the larger mother CP being ready to divide sooner 
than those nuclei with the daughter CP. 
It is not known what signal induces a schizont to stop its asynchronous nuclear divisions 
and undergo a final - and apparently synchronous [13] - division, followed by budding into 
membrane-bound daughter cells. Space or nutrients within the host erythrocyte may become 
limiting, or the timed production of a global cell cycle regulator may be hard-wired into 
Plasmodium’s transcriptional cascade [15]. The latter model could potentially enforce 
synchronicity in the final nuclear division, but it would presumably run the risk of ‘catching’ 
existing nuclei at different stages of S phase. Streipen and co-workers, working largely in the 
related apicomplexan parasite Toxoplasma gondii, have proposed that ‘local’ versus ‘global’ 
control is centrally coordinated by the CPs [3, 16], while a remnant flagellum is the organising 
principle for daughter cell budding [17]. This may also be true for Plasmodium, although 
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schizogony is numerically more complex than endodyogeny in T. gondii and the challenges of its 
coordination may in fact be more analogous to the replication of hyphal yeasts [18]. Overall, 
significant gaps remain in our understanding of the cell biology underlying schizogony, and even 
less is known about the other phases of Plasmodium replication (Fig. 1), for which erythrocytic 
schizogony may yet prove an inadequate model. 
 
Mechanics of DNA replication at the molecular level 
Many early-diverging eukaryotes, such as Trypanosoma and Oxytricha, organise their genomes 
in extremely unusual ways [19, 20]; by comparison, the basic genome structure of Plasmodium 
is quite conventional. There are 14 linear chromosomes with telomeres and centromeres, plus 
two small organellar genomes in the mitochondrion and apicoplast [21]. This conventional 
genome is replicated, however, within the framework of fundamentally unusual cell biology. 
Although much remains to be studied, some of the proteins and parameters involved in this 
process have now begun to be elucidated. 
Plasmodium encodes the basic replicative machinery that is found in all eukaryotes, 
including DNA polymerases [21, 22], proliferating cell nuclear antigen (PCNA) [23, 24] and 
minichromosome maintenance proteins (MCMs) [25, 26]. Components of the Origin 
Recognition Complex (ORC) are also present although only two ORC components have been 
characterised thus far in P. falciparum, PfORC1 and PfORC5 [14, 27], while a putative ORC2 
has been shown to be upregulated during gametocyte activation in P. berghei [28]. The 
remaining members of the complex are either absent or lack sufficient homology with 
characterised members to allow clear identification, although in P. berghei putative homologues 
of ORC4 and ORC3 have recently been proposed [28]. The ORC-associated protein Cdc6 also 
lacks a clear homologue in P. falciparum but a candidate has been proposed in P. berghei [28]. 
Cdc6 is required for the recruitment of Cdt1 and the loading of MCM proteins (to date only a 
putative Cdt1-like gene has been identified in Plasmodium). Interestingly, PfORC1 shares a 
homology region with Cdc6 at the C-terminus and it may, therefore, be regulated in a Cdc6-like 
manner. In S. cerevisiae and humans, the onset of Sphase results in the recruitment of two further 
components to activate the MCM helicase: Cdc45 and the GINS complex (consisting of Sld5, 
Psf1, Psf2 and Psf3). Sequence analysis has failed to identify a clear homologue of Cdc45 in 
Plasmodium, while the members of the GINS complex have been putatively identified, based on 
low sequence homology, but it remains to be determined whether they are functional. 
ORC binds DNA and facilitates the initiation of replication. It recognises a conserved 
consensus sequence in the yeast Saccharomyces cerevisiae, but in other eukaryotes there is no 
consensus sequence and the preferred composition of DNA bound by ORC varies from organism 
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to organism [29]. Putative ORC-binding sequences in P. falciparum have recently been 
identified in silico, based on the AT-rich ORC-binding site of S. cerevisiae (Fig. 3a): they are 
spaced only ~ 2500 bp apart in this highly AT-rich genome and although selected sites do show 
significant enrichment of ORC1 in ChIP assays [30] (Fig. 3b), only a small proportion of these 
sites appear to be used for intra-erythrocytic replication. DNA ‘combing’ of labelled DNA fibres 
was recently used to investigate the actual distribution of active replication forks during 
erythrocytic schizogony (Fig. 3c) and this revealed a mean distance of 65 kb between individual 
origins, with replication forks moving at a mean rate of 1.19 kb/min [31]. The rate of replication 
was not constant, but decreased as the cells neared completion of schizogony, coinciding with a 
reduction in the mean distance between individual origins. Interestingly, this is the opposite of 
the pattern seen in human cells, where replication speeds up and origins become more widely 
spaced as S phase proceeds. In a schizont, which is replicating not 2-fold but ~ 16-fold, the 
availability of nucleotides, the physical space available or the increasing compaction of 
chromatin may all limit the speed of replication as S phase advances [31]. 
During erythrocytic schizogony the first replication (and possible nuclear division) 
requires 4–6 hours [13]. This, however, is not the maximal rate of replication for the parasite. 
After ingestion by a mosquito, male gametocytes undergo a 3-fold replication of their genome in 
less than 15 minutes, resulting in the production of 8 motile microgametes with 1N genome 
content [4, 5]. (Female gametocytes also mature and exit their host cells upon entering a 
mosquito but no replication or cell division occurs.) In the model rodent malaria species P. 
berghei, in which much of the work on gametocytes has been conducted, the first round of 
replication is usually completed within a minute of gametocyte activation [32]. Such extreme 
speed is unprecedented in eukaryotic gametogenesis, and may reflect strong pressure to complete 
the sexual cycle and exit the midgut before the parasite cells are digested along with the blood 
meal. It has yet to be determined whether the replication rate, the number of simultaneously 
active origins or both are significantly increased during gametocyte replication but the question 
of replication fidelity clearly becomes particularly pressing at this unique point in the parasite’s 
life-cycle. If the replication speed remains the same as it is in erythrocytic schizogony, then 
almost all of the suggested ORC-binding sites [30] must be used as origins simultaneously. 
Precedents do exist for such extremely flexible origin usage: in the earliest replications of 
Xenopus embryos, origins occur every 5–15 kb, spacing out only after the mid-blastula transition 
[33]. Plasmodium genome replication may be under similarly flexible control, although nothing 
is yet known about how this might be differentially enforced in gametogenesis, sporogony, 
hepatic and erythrocytic schizogony. 
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Regulation of the Plasmodium cell cycle 
As described above, Plasmodium undergoes multiple unconventional cell cycles, in a variety of 
host cell types and for varying durations. The intricacy and temporal/spatial accuracy with which 
these cell cycles are governed requires global and local regulators that must be fine-tuned and 
potentially equally unconventional. Although the genomic revolution for Plasmodium has 
permitted some investigation of these regulators, our understanding at present is patchy and 
incomplete. 
 
Cyclins and CDKs 
In eukaryotic cells, cell cycle progression is governed by cyclins and cyclin-dependent protein 
kinases (CDKs), along with other proteins such the anaphase promoting complex (APC), which 
promotes waves of cyclin degradation. The interplay between these regulatory and catalytic 
components and their timely upregulation, inhibition and degradation prompts sequential 
progression through G1, S, G2 and M phases [34] (Fig. 2). 
The peculiarities of Plasmodium schizogony begin with the lack of a G2 phase as the 
syncytial nuclei appear to alternate asynchronously between S and M phases prior to the 
orchestrated event of cytokinesis [35] (Fig. 4a). This raises questions about whether control of 
replicative cycles through diffusible cytoplasmic factors is feasible [2, 12]. Although such 
factors may exist, the Apicomplexa have a very unusual repertoire of cyclins, CDKs and CDK-
related kinases (CRKs): in total, three cyclins, Cyc1, Cyc3 and Cyc4 [6], and seven CDK or 
CDK-related kinases, PK5, PK6, Mrk1, Crk-1, Crk-3, Crk-5 [36] and Crk-4 [12], have been 
identified in Plasmodium (Table 2). 
None of the cyclins are homologs of canonical cell-cycle cyclins (e.g. mammalian Cyc D, 
E and A) and they tend to be ubiquitously expressed at many stages and not to ‘cycle’ as seen in 
mammalian cells [6, 37]. Amongst the CDKs, PK5 is the only enzyme that clusters with 
mammalian cell-cycle CDKs; of the others, Mrk1 is the putative functional homologue of CDK7, 
which is both a CDK-activating kinase and a component of the general transcription factor 
TFIIH [38-40], Crk1 and Crk3 are homologous to transcriptional CDKs, and PK6 and Crk5 are 
‘atypical’ CDKs specific to Apicomplexa [41-43]. 
Although PK5 is the putative homologue of mammalian CDK1, Plasmodium encodes no 
cognate cyclins for such an enzyme and the activator for PK5 remains unknown: in vitro, it is 
unusually promiscuous and can be activated by all three Plasmodium cyclins as well as 
mammalian p25, cyclin H and RINGO [37, 44, 45]. The partnership with Cyc1 is questionable 
because recent immunoprecipitation studies failed to identify it [46]. Nevertheless, PK5 has been 
shown to be involved in ORC1 phosphorylation, implicating it in DNA replication in 
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erythrocytic stages [45]. Mrk1 is not apparently a CDK-activating kinase in Plasmodium and 
although it can interact in vitro with the replication factor complex (PfRFC-5) and PfMCM6 
[40], it actually appears to be crucial for cytokinesis rather than replication, as indeed is Cyc1 
[46], with Mrk1 acting in a complex with Cyc1 and MAT1 [46]. Crk5 can be activated in vitro 
by Cyc1 and Cyc4 but its in vivo partner is again unknown; it is involved in, but not essential for, 
erythrocytic schizogony because its absence results in viable parasites with fewer merozoites per 
schizont [43]. PK6 is proposed to be involved in the onset of S phase in erythrocytic stages but in 
vivo characterisation is lacking, and recombinant PK6 is cyclin-independent in vitro [47]. The 
remaining CDKs, Crk-1 and Crk-3, are predicted to have roles in transcriptional regulation and 
thus in cell growth and proliferation [42, 48]. Overall, it is clear that Plasmodium cell cycles are 
not regulated by conventional waves of cyclin/CDK activity, although schizogony and 
sporogony do require Cyc1 and Cyc3, respectively [6, 46], and several CDKs are evidently 
involved. 
 
Non-cyclin/CDK cell cycle regulators 
A host of cell cycle regulators beside the cyclins/CDKs have been identified in Plasmodium (Fig. 
4). Some of these are homologs of conventional eukaryotic regulators, including the NIMA 
kinases (Nek1-4) and the Aurora kinases (Ark1-3): Nek1 plays an essential roles in mitosis [43] 
and Nek2-4, in gametogenesis/meiosis [49-51], while the Arks are involved in mitotic spindle 
formation and cytokinesis [52]. Another - perhaps more interesting - group of regulators are 
specific to the unusual cell cycle modes of apicomplexans and there is considerable interest in 
the plant-like calcium-dependent protein kinases (CDPKs) as possible parasite-specific drug 
targets, with CDPK4 playing multiple roles in male gametogenesis [28] and CDPK7, in 
erythrocytic schizogony [53]. Another Plasmodium-specific kinase, PfCRK4, was recently 
identified as essential for DNA replication in erythrocytic schizogony, although the pathway in 
which it acts remains to be elucidated [12]. The regulation of Plasmodium’s atypical cell cycles 
could clearly be rich source of novel drug targets, but much work is still required to piece 
together the molecular signalling pathways involved. 
 
Cell cycle checkpoints in Plasmodium 
In addition to the cyclin-CDK regulatory network, there are also defined checkpoints in yeast 
and mammalian systems that control cell cycle advancement. These serve as quality control for 
cell growth (G1 checkpoint), successful DNA replication or DNA damage (S and G2 
checkpoints) and chromosome attachment to the spindle (M checkpoint) [54]. Checkpoints are 
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particularly important for avoiding re-replication and preventing the propagation of incompletely 
replicated or damaged daughter genomes. 
The existence of cell cycle checkpoints in Plasmodium remains, in general, uncertain, and 
genes encoding key checkpoint proteins such as Rb, p53, ATM and ATR have not been 
identified. There is, however, some evidence of a G1 checkpoint in the related parasite T. gondii 
[55], and blood-stage Plasmodium parasites can induce a comparable, reversible rest 
state/dormancy at the prereplicative ring stage in response to nutrient starvation [56] and drug 
pressure [57-59]. What induces these states in the absence of a conventional G1 checkpoint 
pathway is unclear. 
DNA repair machinery is largely conserved in the parasite genome, as described below, 
and parasites respond to DNA damage by upregulating repair machinery and altering 
chromosome structure [60]. However, there is no apparent G2, offering no opportunity for a G2 
checkpoint [13, 35] and the feasibility of intra-S and M checkpoints is challenged by the striking 
variation in the speed of genome replication at different life-cycle stages, particularly the 
unprecedented rate in male gametocytes [61], sharply contrasting with a more conventional rate 
during erythrocytic schizogony [13, 31]. Checkpoint regulation may be temporally possible 
during erythrocytic schizogony - and perhaps also oocyst sporogony and hepatic schizogony - 
but not gametogenesis. Spatially, schizogony also poses challenges to checkpoint control. 
Although chromosomes do appear to align with the hemispindle, which is anchored to a CP, they 
remain uncondensed: it is thought that the centromeres remain constantly attached to CPs and 
that this may help to separate the uncondensed chromosomes accurately [3]. Finally, the 
syncytial nature of Plasmodium replication raises questions about diffusible checkpoint factors 
and the how the replication of individual genomes could be stalled within a shared cytoplasm 
[2]. Nevertheless, the observation that schizonts produce very varied numbers of merozoites 
while the erythrocytic cycle is always ~ 48 hours [62] does imply that intra-S or M checkpoints 
may delay some nuclei, and that the time span of schizogony is not imposed by the number of 
merozoites to be produced. 
Variations in cell cycle speed also raise questions about replicative fidelity and tolerance 
of karyotypic variation. Indeed, this parasite’s relentless ability to develop resistance against all 
antimalarials is undoubtedly linked to genomic plasticity, but it remains debatable whether 
plasticity is inherent in the P. falciparum genome, or is actually promoted by unusually relaxed 
cell-cycle control. Under drug pressure, P. falciparum erythrocytic stages can initiate AT-track 
mediated, random duplication of segments of the genome, followed by the establishment of 
pseudopolyploids around a high priority locus. This permits fine-tuning of amplicon numbers, 
relevant to drug pressure, while avoiding genome damage and any deleterious mutations in off-
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target loci [63]. In fact, 20 years ago the concept of ‘hypermutator’ strains specific to certain 
global regions was proposed to explain the fact that drug-resistant parasites regularly arise in 
Southeast Asia [64], but this has proved difficult to evidence, or to link it to any molecular defect 
in DNA repair or checkpoints [65, 66]. Two recent studies have suggested that the mitotic 
mutation rate does not vary between P. falciparum strains and is not increased by drug pressure; 
rather, beneficial resistance mutants are simply selected under drug pressure [67, 68]. In this 
regard, P. falciparum’s active maintenance of a highly AT-biased genome (81% A/T), with high 
insertion/deletion rates and an overrepresentation of homopolymeric A/T tracts [69], may be the 
key to rapid adaptive evolution [70]. 
The extremely fast replication of male gametes raises a particular conundrum in terms of 
checkpoints: does this phase require especially stringent regulation, or conversely, more relaxed 
control to favour speed over fidelity? The observation that some male gametes are produced with 
apparently partial or absent nuclei (unpublished observations) and the fact that male-expressed 
genes display fast rates of evolution [71] may suggest the latter. Proteins involved in DNA 
replication and mitosis are simultaneously phosphorylated within the first 20 seconds of 
gametocyte activation, contrary to the traditional view of sequential progression through the cell 
cycle, and this may facilitate the rapidity of gametogenesis [32]. Indeed, the relatively limited 
repertoire of cell cycle kinases in Plasmodium may also imply that some have dual functions: 
CDPK4 has been implicated in assembly of the pre-replicative complex, mitotic spindle 
formation, cytokinesis and axoneme motility [28, 32, 72]. Extending this concept, highly 
divergent kinases may also operate ‘incognito’ as checkpoint kinases in Plasmodium. 
Regardless of cell cycle speed, the parasite is clearly able to promote genomic diversity 
during mitosis, as well as more conventionally at meiosis. It seems unlikely that the intricacy and 
precision of the Plasmodium cell cycles would proceed unchecked, but evidence is currently 
lacking for clearly defined checkpoints and there may be great flexibility in which checkpoints 
are enforced during different types of replication. 
 
DNA repair in Plasmodium 
DNA damage can originate from a range of sources, the most common in Plasmodium being 
reactive oxygen species generated by metabolism, free radicals, which are often produced after 
uptake of antimalarial drugs such as chloroquine or artemisinin, and errors made during DNA 
replication. Damage may affect individual bases or may lead to the generation of potentially 
deadly double strand breaks (DSBs). The mutational spectrum observed in P. falciparum is 
highly unusual: the SNP mutation rate is 2.45 × 10-10 mutations per base pair per life-cycle but 
this is dwarfed by a 10-fold higher indel mutation rate, driven by low complexity AT-rich 
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sequences and a significant G:C -> A:T transition bias [70]. This can promote the formation of 
pseudopolyploid loci, as described above, but the core genome nevertheless remains intact, due 
to the presence of an effective DNA repair system including most - although notably not all - of 
the pathways commonly found in model eukaryotes. 
Damage to individual bases is resolved by the excision repair pathways that include 
nucleotide excision repair (NER), base excision repair (BER) and mismatch repair (MMR). 
Orthologs of the majority of genes involved in the NER pathway have been identified 
bioinformatically, with the exception of p62 and XPC [73]. Similarly, the majority of the MMR 
pathway is present but there are notable differences from other eukaryotes, with RecJ 
exonucleases appearing to be absent while a UvrD helicase homolog, found in E. coli but absent 
in humans, is present [74, 75]. Plasmodium falciparum lacks homologs for short-patch BER but 
a long-path BER pathway is present [76]. 
The majority of eukaryotes rely upon two major pathways for the repair of double-strand 
breaks, homologous recombination (HR) and non-homologous end joining (NHEJ). The 
Plasmodium genome encodes a functional HR pathway but the core genes of the NHEJ pathway 
appear to be absent across the genus [21, 77], supported by the inability to detect NHEJ products 
in vitro after the experimental generation of DSBs [78, 79]. Accordingly, HR is the prime source 
of DSB repair in the parasite [79-81] (by contrast, T. gondii possesses a functional NHEJ 
pathway, indicating loss of this pathway in Plasmodium [82, 83]). HR, indeed, appears to be 
essential for the completion of the parasite life-cycle because the knockout of a zinc finger 
protein, PbZfp, in P. berghei leads to a loss of transmission competence in mosquitoes due to a 
failure to recruit the topisomerase-like enzyme Spo11 to recombination hotspots [80]. During all 
haploid growth phases the parasite must therefore rely upon alternative end joining pathways 
such as microhomology-mediated end joining (MMEJ) to repair DSBs within the core genome, 
because no repair template exists to allow HR [84]. Bioinformatic comparisons with the S. 
cerevisiae and human genomes have identified Plasmodium orthologs of the MMEJ components, 
but studies of irradiated parasites suggest that the process is inefficient or used infrequently, and 
that parasites with a 1N genome content are unable to repair damage as efficiently as 
trophozoites with genome content of 2N or more [85-87]. 
Notably, this restriction does not apply to multigene families, such as the var family of 
key virulence genes in P. falciparum. There are ~ 60 hypervariable var gene homologs in every 
parasite genome so these can be repaired via HR even in haploid parasites, using homologs 
within the same family. This leads to important diversification of these gene families during 
mitotic growth [68] (as well as during meiosis), generating new antigenic variants that can 
facilitate immune evasion during chronic human infections. Var gene recombination does not 
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require substantial stretches of high sequence homology and the genes do not necessarily 
recombine with their closest homologues [68]; the physical clustering of var genes at the nuclear 
periphery may favour sequence pairing even in the absence of extensive homology. 
 
DNA replication in Plasmodium as a potential drug target 
Historically, DNA replication has been an excellent drug target in malaria parasites, as 
demonstrated by Fansidar: an anti-folate drug combination which proved vital after the 
emergence of chloroquine resistance in the late 1950s [88]. Fansidar is a synergistic combination 
of two drugs that block the pathway to production of reduced folate cofactors (essential for 
nucleotide production and DNA synthesis), but resistance to the combination arose fairly rapidly 
[89, 90]. However, directly targeting the regulatory machinery of the parasite, such as cell-cycle 
checkpoint control, or eliciting DNA damage as a route to parasite killing, may provide a greater 
hurdle to resistance development. Indeed, DNA damage, together with protein damage, is 
thought to be a mode of action for the frontline antimalarial drug artemisinin, mediated through 
free radicals [91]. Plasmodium falciparum responds to artemisinin by inducing dormancy at 
G0/G1, downregulating DNA synthesis-related cyclins/CDKs, upregulating putative ‘negative-
regulatory’ cyclins/CDK’s [35] and upregulating DNA repair machinery - specifically, PfRad51, 
PfRad54, PfRPAIL and PfRPAIS [60, 92]. Artemisinin has also been shown to induce G0/G1 
arrest in Leishmania donovani promastigotes [93] and in multiple cancer cell lines [35]. For 
Plasmodium, understanding the cell cycle arrest phenotype takes on new urgency because it is 
considered a key mechanism of artemisinin resistance [94]. This resistance is not yet fully 
understood in molecular terms, but it correlates with mutations in the Kelch-13 protein, which in 
turn correlate with elevated levels of the phosphoinositide-3-kinase enzyme PfPI3K [95]. 
PfPI3K, a lipid kinase, is distantly related to protein kinases that are key checkpoint proteins in 
most eukaryotes but are missing in Plasmodium - an intriguing similarity that is currently under 
investigation in our laboratory. 
The ability of resistant parasites to survive in a dormant state and recrudesce weeks later 
may be exacerbated by the recent finding that erythrocytic schizogony is remarkably flexible in 
resistant parasites. Resistant clones from Southeast Asia have a prolonged ring stage and 
considerably shortened trophozoite stage, presumably reducing drug exposure to the more 
vulnerable trophozoite [57]. This phenotype was stable without artemisinin drug pressure, which 
is particularly worrying because it could reduce the available window for antimalarials that target 
the trophozoite stage and that may be used as partner drugs in artemisinin combination therapies, 
or as alternative drugs if such therapies fail. 
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Artemisinin resistance first arose at the Thai/Cambodian border, the historic epicentre of 
drug resistance development, and Cambodian isolates have been shown to have a mild mutator 
phenotype and mutations in a number of DNA repair genes, including members of the mismatch 
repair pathway Mlh1, Pms1 and Exo1 [66]. (This is in addition to mutations in the Kelch-13 
propeller domain [96], which serves as a molecular marker for resistance). In bacterial systems, 
mild mutators acquire mutations at a lower rate than hypermutator lines but remain able to purge 
deleterious mutations efficiently from the genome and thus they can outcompete hypermutators 
in the long term [97-100]. A fine balance is clearly required between the need for accuracy and 
adaptability, and this balance has probably shifted in P. falciparum in response to continual 
pressure from antimalarial drug programmes. By analogy with cancer cells - which frequently 
have deficient checkpoint and DNA repair pathways - artemisinin resistant parasites may be on a 
knife edge between efficient growth and the potential disaster of an under-regulated cell cycle, so 
it may be possible to target them with drugs that exacerbate their defects. Proteasome inhibitors 
can synergise with artemisinin by exacerbating the effects of protein damage [101], so perhaps a 
similar strategy to inhibit a crucial checkpoint or DNA repair pathway could exacerbate the 
effects of artemisinin-induced DNA damage. 
A better understanding of cell cycle regulation, checkpoints and repair mechanisms in P. 
falciparum is needed to aid the discovery of compounds that specifically inhibit checkpoints or 
DNA repair. There may also be scope for drugs that target the cell cycle itself, since components 
such as the cyc-CDK machinery are distinct from human counterparts. Indeed, like many 
Plasmodium proteins, some conserved replication proteins also have distinct N-terminal 
extensions or inserted domains that could serve as highly specific drug targets. Such discoveries 
could not only circumvent artemisinin resistance but could also identify a much-needed novel 
class of antimalarial agents. Recently, the CDK inhibitors olomoucine (PfCRK1, PfPK5 and 
PfPK6 inhibitor), roscovitine (PfPK5 and PfPK6 inhibitor) and WR636638 (chalcone inhibitor 
of PfMRK) were shown to have differential effects on artemisinin induced dormancy [35]. The 
DNA synthesis inhibitor aphidicolin and PfPK5 inhibitor flavopiridol also decrease DNA 
replication in malaria parasites [102]. Overall, the very fact that artemisinin is effective validates 
DNA damage as a drug target, but the looming catastrophe of widespread artemisinin resistance 
urgently demands a better understanding of the resistance mechanism, its relationship with DNA 
repair machinery, and with the control of the Plasmodium cycle cell as a whole. 
 
State-of-the-art focus: Experimental techniques to study the Plasmodium cell 
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Investigation of the Plasmodium cell cycle has been hampered a lack of transferable techniques 
from other well-studied systems. Erythrocytic schizogony has been most thoroughly investigated 
because the blood stages of P. falciparum are relatively easy to culture. However, during 
schizogony the small size of nuclei (diameter > 1 µm) limits the resolution of 
immunofluorescence microscopy and the multiple asynchronous rounds of replication 
complicate flow cytometric definition of S phase parasites based upon DNA content. 
Furthermore, synchronization of blood-stage parasites, beyond age-range categories or 
morphological classification via microscopy, has been problematic because the most commonly 
used agents for chemically synchronising cells at a precise cell-cycle boundary are ineffective in 
Plasmodium [103]. 
Fortunately, in recent years significant technological advances have occurred that will 
facilitate the study of the Plasmodium cell cycle. The advent of bromodeoxyuridine (BrdU) 
labelling for Plasmodium [104] means that accurate detection of S phase entry and tracing of de 
novo DNA synthesis is now possible (Fig. 3c). CRK4 depletion in P. falciparum has been shown 
halt DNA replication [12] and might be exploited as a valuable synchronisation tool. Progress in 
reverse-genetic techniques such as Crispr/Cas9 [105], Selection linked integration (SLI) [106], 
and the DiCre system for conditional knockdown [107] have improved the genetic tractability 
and speed of genetic experiments in the parasite. Such techniques can undoubtedly help to 
further characterise the cyclin/CDK machinery and the elusive checkpoint systems in 
Plasmodium. Along with advances in imaging methods, such as improved deconvolution of 
widefield microscopy, super resolution techniques and spinning disk confocal microscopy, we 
are now better equipped than ever to study the cell cycles of Plasmodium. 
 
Conclusion 
This review summarises our current knowledge about the events of the Plasmodium cell cycles 
at both the cellular and molecular levels, emphasising many areas of incomplete understanding. 
The cell cycles pursued by this parasite vary enormously at different life-cycle stages, and even 
the most accessible of these, which can be grown readily in vitro in human erythrocytes, urgently 
demands further study. This is especially so because of the great potential for novel drug targets 
in this area of Plasmodium biology. The increasing availability of experimental tools for such 
work means that there has never been a better time to advance our understanding of the cell cycle 
in this globally important human parasite. 
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APC: anaphase promoting complex; Ark: Aurora kinase; ARS: autonomously replicating 
sequence; BER: base excision repair; BrdU/CldU/IdU: bromo/chloro/iodo-deoxyuridine; CDK: 
cyclin dependent kinase; CDPK: calcium-dependent protein kinase; ChIP: chromatin immuno-
precipitation; CP: centriolar plaque; CRK: CDK-related kinase; DSB: DNA double strand break; 
hpi: hours post-invasion; HR: homologous recombination; MCM: minichromosome maintenance 
protein; MMEJ: microhomology-mediated end joining; MMR: mismatch repair; Nek: NIMA 
kinase; NER: nucleotide excision repair; NHEJ: non-homologous end joining; ORC: Origin 
Recognition Complex; PCNA: proliferating cell nuclear antigen; Pb: Plasmodium berghei; Pf: 
Plasmodium falciparum; RFC: replication factor complex; SLI: Selection linked integration. 
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FIGURE LEGENDS  
Fig. 1 Schematic showing the life-cycle of P. falciparum. Each replicative stage of the life-cycle, 
together with the approximate fold-replication, is highlighted in purple. Approximate parasite 
numbers within each host at each stage are also shown to highlight the severe bottlenecks and 
massive expansions that occur throughout the life-cycle 
 
Fig. 2 Schematic of the conventional eukaryotic cell cycle, highlighting the points at which cycle 
checkpoints operate 
 
Fig. 3 Development of techniques to examine the replication of the Plasmodium genome. a 
Bioinformatic analysis of conserved sequences at and surrounding replication origins in the S. 
cerevisiae genome has led to identification of common motifs for searching the Plasmodium 
genome [30]. Origins in S. cerevisiae consist of compact autonomously replicating sequences 
(ARS) with ‘A domain’ motifs (orange) and surrounding ‘B domains’ (green). The Plasmodium 
genome has a high concentration of individual A and B domains (~ every 2500 bp) but a much 
lower concentration when the requirement for closely associated domains is imposed (grey 
boxes). Bioinformatics approaches can only identify putative origin sites and may fail to identify 
true origins (*) or identify sequences which are incapable of functioning as origins. b Chromatin 
immuno-precipitation (ChIP) of the proteins required before and during replication, such as 
members of the Origin Recognition Complex (ORC), allows experimental characterisation of 
origin sequences [30]. Following reversible DNA-protein cross linking, the genome is 
fragmented and the proteins of interest are purified along with the associated DNA fragments, 
which are then sequenced. This may include origins that would never be activated, and may miss 
those where the protein complex has dissociated from the chromosome. c Synthetic nucleoside 
labelling and DNA combing techniques allow the labelling and fluorescent immunodetection of 
de novo DNA synthesis [31]. Parasites expressing viral thymidine kinase can incorporate the 
synthetic nucleosides IdU (red) and CldU (green) which can be visualised in individual nuclei or 
on combed DNA fibres, allowing the calculation of inter-origin distances and replication rates. 
The synthetic nucleosides will only be incorporated around active origins (*) while inactive 
origins will remain unlabelled and therefore undetected 
 
Fig. 4 Illustration of cell cycle phases in Plasmodium erythrocytic schizogony and Plasmodium 
male gametogenesis. The predicted involvement of cyclins, CDKs and other kinases is shown at 
each phase. Placement of such components is only loosely chronological since most details are 
unknown. CDKs/Crks with a dashed outline indicate cyclin independence. Crks or CDKs 
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predicted to be involved in transcriptional regulation are transparent (without a white 
background). Interactions identified in vitro between cyclins and CDKs are indicated by a 
dashed orange arrow. Table 2 identifies all sources used to construct the figure. The cell cycles at 
sporogony and hepatic schizogony are omitted due to the lack of information about these stages 
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Table 1 Summary of replicative stages in the P. falciparum life-cycle 
Replicative 
stage 
Host Time 
period 
Daughter 
cells 
Rounds of 
replication 
Time available per 
genome replication 
Key 
references 
Hepatic 
schizogony 
Human (liver) ~ 7 
days 
> 10,000 ~ 14 ~ 12 h [108, 109] 
Erythrocytic 
schizogony 
Human 
(bloodstream) 
48 h ~ 16–20 4–5 ~ 4 h [13] 
Gametogenesis Mosquito 15 min 8 3 < 4 min [4, 110] 
Sporogony Mosquito ~ 10 
days 
~ 10,000 ~ 14 ~ 17 h [111, 112] 
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Table 2 Regulators and their action in Plasmodium cell cycles 
Regulator Stage of life-cyclea Cell cycle action Gene ID Reference 
Cyclin Cyc1 Erythrocytic stages (Pf) 
(peak expression in 
trophozoite) 
Binds PfPK5 (in vitro) and 
PfMrk1 (in vivo). Role in 
segmentation 
PF3D7_1463700; 
PBANKA_12332
00 
[44, 46, 113]  
 Cyc3 Oocyst formation (Pb) Binds PfPK5 (in vitro) PF3D7_0518400 
(putative); 
PBANKA_12332
00 
[6] 
 Cyc4 Unknown Activates PfCrk-5 in vitro PF3D7_1304700; 
PBANKA_14032
00 (putative) 
[43] 
CDKs PK5 Erythrocytic schizogony 
(Pf) 
DNA synthesis PF3D7_1356900; 
PBANKA_11332
00 
[40, 45] 
 Mrk Erythrocytic schizogony 
(Pf) (mRNA, however, 
more abundant in 
gametocytes than in 
asexuals) 
Cytokinesis in erythrocytic 
schizogony (Pf). 
Transcriptional regulator? 
PF3D7_1014400; 
PBANKA_12128
00 
[38, 44, 46] 
 PK6 Erythrocytic schizogony 
(trophozoite) 
Onset of S phase (cyclin 
independent) 
PF3D7_1337100; 
PBANKA_13509
00 
[47] 
Crks Crk-1 Gametocytes (Pf) 
Erythrocytic schizogony 
(Pb) 
Transcriptional regulator PF3D7_0417800; 
PBANKA_07199
00 
[114, 115] 
 Crk-3 Erythrocytic schizogony 
(Pf) 
Transcriptional regulator PF3D7_0415300; 
PBANKA_07173
00 
[42] 
 Crk-5 Erythrocytic schizogony 
(Pf) 
Proliferation - number of 
merozoites. Activated by 
Cyc 1 and 4 in vitro. Cyclin 
independent? 
PF3D7_0615500; 
PBANKA_12302
00 
[43] 
Other 
Kinases 
CDPK4 Gametogenesis (Pb) Mitotic spindle assembly PF3D7_0717500; 
PBANKA_06152
00 
[28] 
 CDPK7 Erythrocytic schizogony 
(Pf) 
Unknown PF3D7_1123100; 
PBANKA_09252
00 
[53] 
 Crk-4 Erythrocytic schizogony 
(trophozoite/schizont) 
S phase PF3D7_0317200; 
PBANKA_08080
[12] 
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(Pf) 00 (putative) 
 Nek-1 Erthrocytic schizogony/ 
Gametogenesis (Pb) 
Mitosis PF3D7_1228300; 
PBANKA_14430
00 (putative) 
[116] 
 Nek-2 Zygote (Pb) Meiosis PF3D7_0525900; 
PBANKA_12407
00 
[49, 50] 
 Nek-3 Erythrocytic schizogony/ 
Gametogenesis (Pb) 
Unknown PF3D7_1201600; 
PBANKA_06006
00 (putative) 
[117] 
 Nek-4 Zygote (Pb) Meiosis PF3D7_0719200; 
PBANKA_06167
00 
[49, 50] 
 Ark1 Erythrocytic schizogony/ 
Gametogenesis (Pb) 
Mitotic spindle formation/ 
Cytokinesis 
PF3D7_0605300; 
PBANKA_01041
00 
[52] 
 Ark2 Erythrocytic schizogony/ 
Gametogenesis (Pb) 
Mitotic spindle formation/ 
Cytokinesis 
PF3D7_0309200; 
PBANKA_04074
00 
[52] 
 Ark3 Erythrocytic schizogony/ 
Gametogenesis (Pb) 
Mitotic spindle formation/ 
Cytokinesis 
PF3D7_1356800; 
PBANKA_11331
00 
[52] 
aInformation has been compiled from studies completed with either Plasmodium falciparum (Pf) 
or Plasmodium berghei (Pb) as indicated 
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